Nasdaq · CIK 0001378325
CV CapsoVision, Inc
Insider trading from SEC Form 4. Last filing 19 d ago. Close $6.59 on Oct 9, 2026, +48% from the 52-week low and -54% from the high.
Last 90 days
Net insider value
+$20M
more bought than sold
Buys
3
$20M by 2 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Price and insider trades, last year
CVOct 9, 2026 · close 6.59
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at CapsoVision, Inc, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Harari Eliyahou Et Al owner buy | $10.0M 1,757,469 shares | +339% | - | |
| 43Moderate | Ching Hang Shen owner buy | $5.0M 878,734 shares | +14% | - | |
| 46Moderate | Ching Hang Shen owner buy | $5.0M 878,734 shares | +43% | - | |
| 23Weak | Chen Lung Tsai director buy | $83 20 shares | - | +26% from low0% from high |
Transactions
The last 75 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Ching Hang Shen owner | POpen-market purchase Common stockindirect: Star One Global Capital Limited | +878,734 | $5.69 | $5.0M | 7,279,261 | 19 d ago |
| Apr 17, 2026 | Ching Hang Shen owner | JOther Common stock | -3,991,606 | $0.00 | $0 | 0 | 19 d ago |
| Sep 18, 2026 | Harari Eliyahou Et Al owner | POpen-market purchase Common Stockindirect: By trust. | +878,735 | $5.69 | $5.0M | 1,396,494 | 19 d ago |
| Sep 18, 2026 | Harari Eliyahou Et Al owner | POpen-market purchase Common Stockindirect: By trust. | +878,734 | $5.69 | $5.0M | 878,734 | 19 d ago |
| Apr 17, 2026 | Ching Hang Shen owner | JOther Common stockindirect: Star One Global Capital Limited | +3,991,606 | $0.00 | $0 | 6,400,527 | 19 d ago |
| Sep 15, 2026 | Ching Hang Shen owner | POpen-market purchase Common stockindirect: Star One Global Capital Limited | +878,734 | $5.69 | $5.0M | 2,926,655 | 24 d ago |
| Mar 19, 2026 | Julia S Gouw director | AGrant or award Restricted Stock Unit (RSU)derivative | +4,045 | $0.00 | $0 | 4,045 | Mar 23, 2026 |
| Mar 19, 2026 | Chen Lung Tsai director | AGrant or award Restricted Stock Unit (RSU)derivative | +4,045 | $0.00 | $0 | 4,045 | Mar 23, 2026 |
| Mar 19, 2026 | Michele Harari director | AGrant or award Restricted Stock Unit (RSU)derivative | +4,045 | $0.00 | $0 | 4,045 | Mar 23, 2026 |
| Mar 19, 2026 | Wen-Herng Henry King director | AGrant or award Restricted Stock Unit (RSU)derivative | +4,045 | $0.00 | $0 | 4,045 | Mar 23, 2026 |
| Mar 19, 2026 | Hui Ying Kuo director | AGrant or award Restricted Stock Unit (RSU)derivative | +4,045 | $0.00 | $0 | 4,045 | Mar 23, 2026 |
| Mar 19, 2026 | Joanne Carol Imperial director | AGrant or award Restricted Stock Unit (RSU)derivative | +4,045 | $0.00 | $0 | 4,045 | Mar 23, 2026 |
| Jul 3, 2025 | Chen Lung Tsai director | POpen-market purchase Common Stock | +20 | $4.17 | $83 | 20 | Feb 6, 2026 |
| Dec 31, 2025 | Chen Lung Tsai director | MOption exercise Common Stock | +2,887 | $10.69 | $31k | 2,887 | Dec 31, 2025 |
| Dec 31, 2025 | Julia S Gouw director | MOption exercise Common Stock | +2,887 | $10.69 | $31k | 2,887 | Dec 31, 2025 |
| Dec 31, 2025 | Joanne Carol Imperial director | MOption exercise Common Stock | +2,887 | $10.69 | $31k | 2,887 | Dec 31, 2025 |
| Dec 31, 2025 | Hui Ying Kuo director | MOption exercise Common Stock | +2,887 | $10.69 | $31k | 13,241 | Dec 31, 2025 |
| Dec 31, 2025 | Wen-Herng Henry King director | MOption exercise Common Stock | +2,887 | $10.69 | $31k | 23,597 | Dec 31, 2025 |
| Dec 31, 2025 | Michele Harari director | MOption exercise Common Stock | +2,887 | $10.69 | $31k | 59,043 | Dec 31, 2025 |
| Dec 31, 2025 | Wen-Herng Henry King director | MOption exercise Restricted Stock Unit (RSU)derivative | -2,887 | $0.00 | $0 | 0 | Dec 31, 2025 |
| Dec 31, 2025 | Julia S Gouw director | MOption exercise Restricted Stock Unit (RSU)derivative | -2,887 | $0.00 | $0 | 0 | Dec 31, 2025 |
| Dec 31, 2025 | Joanne Carol Imperial director | MOption exercise Restricted Stock Unit (RSU)derivative | -2,887 | $0.00 | $0 | 0 | Dec 31, 2025 |
| Dec 31, 2025 | Hui Ying Kuo director | MOption exercise Restricted Stock Unit (RSU)derivative | -2,887 | $0.00 | $0 | 0 | Dec 31, 2025 |
| Dec 31, 2025 | Michele Harari director | MOption exercise Restricted Stock Unit (RSU)derivative | -2,887 | $0.00 | $0 | 0 | Dec 31, 2025 |
| Dec 31, 2025 | Chen Lung Tsai director | MOption exercise Restricted Stock Unit (RSU)derivative | -2,887 | $0.00 | $0 | 0 | Dec 31, 2025 |
| Nov 3, 2025 | David Michael Garcia Sr. VP of Finance | AGrant or award Stock Option (right to buy)derivative | +165,000 | $0.00 | $0 | 165,000 | Nov 3, 2025 |
| Sep 15, 2025 | Julia S Gouw director | AGrant or award Restricted Stock Unit (RSU)derivative | +2,887 | $0.00 | $0 | 2,887 | Sep 17, 2025 |
| Sep 15, 2025 | Joanne Carol Imperial director | AGrant or award Restricted Stock Unit (RSU)derivative | +2,887 | $0.00 | $0 | 2,887 | Sep 17, 2025 |
| Sep 15, 2025 | Hui Ying Kuo director | AGrant or award Restricted Stock Unit (RSU)derivative | +2,887 | $0.00 | $0 | 2,887 | Sep 17, 2025 |
| Sep 15, 2025 | Wen-Herng Henry King director | AGrant or award Restricted Stock Unit (RSU)derivative | +2,887 | $0.00 | $0 | 2,887 | Sep 17, 2025 |
| Sep 15, 2025 | Chen Lung Tsai director | AGrant or award Restricted Stock Unit (RSU)derivative | +2,887 | $0.00 | $0 | 2,887 | Sep 17, 2025 |
| Sep 15, 2025 | Michele Harari director | AGrant or award Restricted Stock Unit (RSU)derivative | +2,887 | $0.00 | $0 | 2,887 | Sep 17, 2025 |
| Aug 18, 2025 | Rebecca Ann Petersen Director of Clinical Affairs | MOption exercise Common Stock | +24,834 | $0.37 | $9,097 | 24,834 | Aug 22, 2025 |
| Aug 18, 2025 | Rebecca Ann Petersen Director of Clinical Affairs | MOption exercise Stock Option (right to buy)derivative | -7,507 | $0.00 | $0 | 0 | Aug 22, 2025 |
| Aug 18, 2025 | Rebecca Ann Petersen Director of Clinical Affairs | MOption exercise Stock Option (right to buy)derivative | -17,327 | $0.00 | $0 | 3,694 | Aug 22, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Common Stockindirect: By trust. | +3,186,904 | - | - | 3,186,904 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Common Stockindirect: By trust. | +3,186,904 | - | - | 3,186,904 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Common Stockindirect: By trust. | +517,759 | - | - | 517,759 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Common Stockindirect: By trust. | +517,759 | - | - | 517,759 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Common Stockindirect: By trust. | +517,759 | - | - | 517,759 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Common Stockindirect: By trust. | +517,759 | - | - | 517,759 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series D-1 Preferred Stockderivativeindirect: By trust. | -222,222 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series D-1 Preferred Stockderivativeindirect: By trust. | -222,222 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series D-2 Preferred Stockderivativeindirect: By trust. | -934,588 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series D-2 Preferred Stockderivativeindirect: By trust. | -934,588 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series E Preferred Stockderivativeindirect: By trust. | -434,782 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series E Preferred Stockderivativeindirect: By trust. | -434,782 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series F-1 Preferred Stockderivativeindirect: By trust. | -434,783 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series F-1 Preferred Stockderivativeindirect: By trust. | -434,783 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series F-2 Preferred Stockderivativeindirect: By trust. | -2,000,000 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series F-2 Preferred Stockderivativeindirect: By trust. | -2,000,000 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series G Preferred Stockderivativeindirect: By trust. | -740,741 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series G Preferred Stockderivativeindirect: By trust. | -740,741 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series G-1 Preferred Stockderivativeindirect: By trust. | -1,206,898 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series G-1 Preferred Stockderivativeindirect: By trust. | -1,206,898 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series H Preferred Stockderivativeindirect: By trust. | -4,638,377 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series H Preferred Stockderivativeindirect: By trust. | -4,638,377 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series H Preferred Stockderivativeindirect: By trust. | -1,724,139 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series H Preferred Stockderivativeindirect: By trust. | -1,724,139 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series H Preferred Stockderivativeindirect: By trust. | -1,724,139 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Harari Eliyahou Et Al owner | CConversion Series H Preferred Stockderivativeindirect: By trust. | -1,724,139 | $0.00 | $0 | 0 | Jul 8, 2025 |
| Jul 3, 2025 | Kang-Huai Wang See Remarks | CConversion Common Stock | +446,896 | - | - | 721,732 | Jul 7, 2025 |
| Jul 3, 2025 | Wen-Herng Henry King director | CConversion Common Stock | +20,710 | - | - | 20,710 | Jul 7, 2025 |
| Jul 3, 2025 | Hui Ying Kuo director | CConversion Common Stock | +10,354 | - | - | 10,354 | Jul 7, 2025 |
| Jul 3, 2025 | Chen Lung Tsai director | CConversion Common Stockindirect: By trust. | +91,432 | - | - | 115,456 | Jul 7, 2025 |
| Jul 3, 2025 | Wen-Herng Henry King director | CConversion Series H Preferred Stockderivative | -68,966 | $0.00 | $0 | 0 | Jul 7, 2025 |
| Jul 3, 2025 | Hui Ying Kuo director | CConversion Series H Preferred Stockderivative | -34,482 | $0.00 | $0 | 0 | Jul 7, 2025 |
| Jul 3, 2025 | Chen Lung Tsai director | CConversion Series B Preferred Stockderivativeindirect: By trust. | -71,429 | $0.00 | $0 | 0 | Jul 7, 2025 |
| Jul 3, 2025 | Kang-Huai Wang See Remarks | CConversion Series A Preferred Stockderivative | -1,407,407 | $0.00 | $0 | 0 | Jul 7, 2025 |
| Jul 3, 2025 | Chen Lung Tsai director | CConversion Series D-1 Preferred Stockderivativeindirect: By trust. | -55,555 | $0.00 | $0 | 0 | Jul 7, 2025 |
| Jul 3, 2025 | Kang-Huai Wang See Remarks | CConversion Series C-1 Preferred Stockderivative | -33,707 | $0.00 | $0 | 0 | Jul 7, 2025 |
| Jul 3, 2025 | Chen Lung Tsai director | CConversion Series E Preferred Stockderivativeindirect: By trust. | -86,956 | $0.00 | $0 | 0 | Jul 7, 2025 |
| Jul 3, 2025 | Kang-Huai Wang See Remarks | CConversion Series D Preferred Stockderivative | -11,111 | $0.00 | $0 | 0 | Jul 7, 2025 |
| Jul 3, 2025 | Chen Lung Tsai director | CConversion Series H Preferred Stockderivativeindirect: By trust. | -90,534 | $0.00 | $0 | 0 | Jul 7, 2025 |
| Jul 3, 2025 | Kang-Huai Wang See Remarks | CConversion Series H Preferred Stockderivative | -35,947 | $0.00 | $0 | 0 | Jul 7, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Julia S Gouwdirector
- David Michael GarciaSr. VP of Finance
- Harari Eliyahou Et Alowner
- Michele Hararidirector
- Joanne Carol Imperialdirector
- Wen-Herng Henry Kingdirector
- Hui Ying Kuodirector
- Rebecca Ann PetersenDirector of Clinical Affairs
- Ching Hang Shenowner
- Chen Lung Tsaidirector
- Kang-Huai WangSee Remarks
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.